Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 9/20 | 0.60 |
| ▸ | CNR1 | P21554 | 8/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.40 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.40 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL88033 | 0.92 | CNR2 (0.69) | CNR2CNR1ALDH1A1DNM1LPAR6 | |
| SCHEMBL29343932 | 0.91 | TSHR (0.54) | CNR2CNR1ALDH1A1DNM1TSHR | |
| SCHEMBL9243523 | 0.90 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1LPAR6 | |
| SCHEMBL223184 | 0.90 | CNR2 (0.52) | CNR2CNR1ALDH1A1DNM1TSHR | |
| SCHEMBL2216579 | 0.90 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1LPAR6 | |
| SCHEMBL3793537 | 0.90 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1LPAR6 | |
| SCHEMBL2342987 | 0.90 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1LPAR6 | |
| SCHEMBL100166 | 0.90 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1LPAR6 | |
| SCHEMBL6417540 | 0.90 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1LPAR6 | |
| SCHEMBL2218924 | 0.90 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1LPAR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1639072-A1 | SOLVENT TREATMENT OF FABRIC ARTICLES | The Procter & Gamble Company (US) | 2006-03-29 | — | — | EP | claimed |
| US-20050223500-A1 | Solvent treatment of fabric articles | THE PROCTER & GAMBLE COMPANY | 2005-10-13 | — | — | US | claimed |
| WO-2005003278-A1 | SOLVENT TREATMENT OF FABRIC ARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2005-01-13 | — | — | WO | claimed |
| US-12227711-B2 | Formulation and cetane improvement based on organic nitrates for alcohol-based renewable diesel fuel | FALQUETE MARCO ANTONIO (BR) | 2025-02-18 | — | — | US | disclosed |
| US-20240166963-A1 | RENEWABLE DIESEL FUEL FORMULATION BASED ON ALCOHOLS | FALQUETE MARCO ANTONIO (BR) | 2024-05-23 | — | — | US | disclosed |
| EP-3965722-B1 | TOPICAL COMPOSITIONS WITH PRESERVATIVE SYSTEM | DSM IP ASSETS BV (NL) | 2023-08-16 | — | — | EP | disclosed |
| EP-3965721-B1 | TOPICAL COMPOSITIONS WITH ANTIMICROBIAL AGENT MIXTURE | DSM IP ASSETS BV (NL) | 2023-06-14 | — | — | EP | disclosed |
| US-20230174454-A1 | PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE | GENOMATICA, INC. | 2023-06-08 | — | — | US | disclosed |
| EP-4149918-A1 | PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE | Genomatica, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| WO-2022183263-A1 | CETANE IMPROVERS FOR DIESEL CYCLE FUELS | FALQUETE MARCO ANTONIO (BR) | 2022-09-09 | — | — | WO | disclosed |
| US-20220211594-A1 | TOPICAL COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2022-07-07 | — | — | US | disclosed |
| WO-2007144335-A1 | CRUDE GLYCEROL-BASED PRODUCT, PROCESS FOR ITS PURIFICATION AND ITS USE IN THE MANUFACTURE OF DICHLOROPROPANOL | SOLVAY (SOCIETE ANONYME) (BE) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007100808-A2 | METHOD AND PROCESS FOR PREPARING CARDIOLIPIN | NEOPHARM, INC. (US) | 2007-09-07 | — | — | WO | disclosed |
| US-20070043234-A1 | Use of functionalized onium salts as a soluble support for organic synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-02-22 | — | — | US | disclosed |
| EP-1262502-A1 | A printing relief and an adhesive material for making the same | Kyoeisha Chemical Co., Ltd. (JP) | 2002-12-04 | — | — | EP | disclosed |
| US-20020174946-A1 | Printing relief and an adhesive material for making the same | KYOEISHA CHEMICAL CO., LTD. (JP) | 2002-11-28 | — | — | US | disclosed |
| CN-1068171-C | Agricultural formulations | DOW AGROSCIENCES CORP (US) | 2001-07-11 | — | — | CN | disclosed |
| US-6083563-A | ELECTRODEPOSITION COATING BAKED ON SURFACE | NIPPON PAINT CO., LTD. (JP) | 2000-07-04 | — | — | US | disclosed |
| CN-1219953-A | Fabric softening compound/composition | PROCTER & GAMBLE (US) | 1999-06-16 | — | — | CN | disclosed |
| CN-1107273-A | Improved agricultural formulations | DOWELANCO (US) | 1995-08-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174454-A1 | PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE | CYP8B1, GRHPR, HCAR3 | CNR2 902/4885CNR1 582/4885ALDH1A1 967/4885 |
| US-20070043234-A1 | Use of functionalized onium salts as a soluble support for organic synthesis | NOS1, NOS2, F12 | CNR2 3430/4885CNR1 2457/4885ALDH1A1 1010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.